Übersetzung für 'FEV1' von Englisch nach Deutsch

forced expiratory volume in one / 1 second <FEV1>

Einsekundenkapazität {f} <FEV1>med.

forciertes Exspirationsvolumen {n} in einer / 1 Sekunde <FEV1>med.

• In restrictive lung disease, both forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) are reduced, however, the decline in FVC is more than that of FEV1, resulting in a higher than 80% FEV1/FVC ratio.
• A positive response is usually a decrease in baseline FEV1 of 15 to 20 percent.
• This theory is supported by the fact that patients with high periostin levels responded significantly better to lebrikizumab in the Phase II study: the forced expiratory volume in 1 second (FEV1) was 8.2% higher than under placebo in this group (measured from the respective baselines), while low-periostin patients had 1.6% higher FEV1, and the average value for all patients was 5.5%.
• Specific inhalation challenges test consist of exposing the subjects to the suspected occupational agent in the laboratory and/or at the workplace and assess for asthma symptoms as well as a reduction in FEV1.
• Caffeine improves airway function in asthma, increasing forced expiratory volume (FEV1) by 5% to 18%, with this effect lasting for up to four hours.

  ---

• FEV1 (forced expiratory volume in 1 second) should be above 80% of predicted values to be considered normal. Bronchiolitis obliterans reduces this to between 16% and 21%.
• A decreased FEV1/FVC ratio (versus the normal of about 80%) is indicative of airway obstruction, as the normal amount of air can no longer be exhaled in the first second of expiration.
• Patients with byssinosis show a significant drop in FEV1 over the course of work shift.
• On spirometry, as a restrictive lung disease, both the FEV1 (forced expiratory volume in 1 second) and FVC (forced vital capacity) are reduced so the FEV1/FVC ratio is normal or even increased in contrast to obstructive lung disease where this ratio is reduced.
• A phase III trial showed people treated with elexacaftor/tezacaftor/ivacaftor improved in FEV1 at four weeks with sustained improvement at 24 weeks.

  ---

• In the first study lasting a year, after 26 weeks of treatment the combination improved participants' FEV1 (the maximum volume of air a person can breathe out in one second) by 82 ml before a dose and 261 ml after a dose.
• Forced vital capacity (FVC) is the volume of air that can forcibly be blown out after full inspiration, Average values for FEV1 in healthy people depend mainly on sex and age, according to the diagram.
• If there is no evidence of undue shortness of breath or diffuse parenchymal lung disease, and the FEV1 exceeds 2 litres or 80% of predicted, the person is fit for pneumonectomy.
• In a second trial conducted in children age six to 11, the average improvement in FEV1 was an absolute increase of 12.5% in the ivacaftor group at 48 weeks, compared to a very slight decline in the placebo group.
• This is typically based on the FEV1 expressed as a percentage of the predicted "normal" for the person's age, gender, height and weight.

  ---

• An increase in FEV1 (or forced expiratory volume in the first second of a forced exhalation) of >200ml is considered a positive result.